[artículo] 
inThe American Journal of Psychiatry > Año 2025 - Vol. 182 - No.1 (Enero) . - pp. 33-46

Título :	Benefits and challenges of ultra-fast, short-acting psychedelics in the treatment of depression
Tipo de documento:	texto impreso
Autores:	Johannes G. Ramaekers, Autor ; Johannes T. Reckweg, Autor ; Natasha L. Mason, Autor
Fecha de publicación:	2025
Artículo en la página:	pp. 33-46
Idioma :	Inglés (eng) Idioma original : Inglés (eng)
Etiquetas:	5-MeO-DMT, DMT, Depresión, Psicodélicos.
Resumen:	Unlike classical antidepressants, psychedelics such as psilocybin have been shown to induce a rapid antidepressant response. In the wake of this development, interest has emerged in ultra-fast, short-acting psychedelics such as 5-methoxy-N,N-dimethyltryptamine (5-MeO-DMT) and N,N-dimethyltryptamine (DMT) with the expectation that these can produce rapid antidepressant effects following an intense but brief psychedelic intervention.
Link:	./index.php?lvl=notice_display&id=31557

[artículo] Benefits and challenges of ultra-fast, short-acting psychedelics in the treatment of depression [texto impreso] / Johannes G. Ramaekers, Autor ; Johannes T. Reckweg, Autor ; Natasha L. Mason, Autor . - 2025 . - pp. 33-46.
Idioma : Inglés (eng) Idioma original : Inglés (eng)
in The American Journal of Psychiatry > Año 2025 - Vol. 182 - No.1 (Enero) . - pp. 33-46

Etiquetas:	5-MeO-DMT, DMT, Depresión, Psicodélicos.
Resumen:	Unlike classical antidepressants, psychedelics such as psilocybin have been shown to induce a rapid antidepressant response. In the wake of this development, interest has emerged in ultra-fast, short-acting psychedelics such as 5-methoxy-N,N-dimethyltryptamine (5-MeO-DMT) and N,N-dimethyltryptamine (DMT) with the expectation that these can produce rapid antidepressant effects following an intense but brief psychedelic intervention.
Link:	./index.php?lvl=notice_display&id=31557